WO2003025570A1 - Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same - Google Patents
Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same Download PDFInfo
- Publication number
- WO2003025570A1 WO2003025570A1 PCT/JP2002/009558 JP0209558W WO03025570A1 WO 2003025570 A1 WO2003025570 A1 WO 2003025570A1 JP 0209558 W JP0209558 W JP 0209558W WO 03025570 A1 WO03025570 A1 WO 03025570A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ability
- vector
- strand rna
- lowered
- rna virus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18861—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003529148A JPWO2003025570A1 (ja) | 2001-09-18 | 2002-09-18 | 粒子形成能が低下した(−)鎖rnaウィルスベクターの検査方法および製造方法 |
KR10-2004-7003888A KR20040039366A (ko) | 2001-09-18 | 2002-09-18 | 입자 형성능이 저하된 (-)가닥 rna 바이러스 벡터의 검사방법 및 제조방법 |
CA002460778A CA2460778A1 (en) | 2001-09-18 | 2002-09-18 | Methods for testing and producing (-) strand rna virus vectors with reduced particle formation ability |
US10/489,384 US20050130123A1 (en) | 2001-09-18 | 2002-09-18 | Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same |
EP20020765579 EP1437593A1 (en) | 2001-09-18 | 2002-09-18 | Method of examining (-)-strand rna virus vector having lowered ability to form grains and method of constructing the same |
US10/316,538 US20030166252A1 (en) | 1999-05-18 | 2002-12-10 | Paramyxovirus-derived RNP |
US10/316,535 US7226786B2 (en) | 1999-05-18 | 2002-12-10 | Envelope gene-deficient Paramyxovirus vector |
US11/515,341 US20070009949A1 (en) | 1999-05-18 | 2006-09-01 | Paramyxovirus-derived RNP |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001283451 | 2001-09-18 | ||
JP2001-283451 | 2001-09-18 | ||
JP2001356336 | 2001-11-21 | ||
JP2001-356336 | 2001-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003025570A1 true WO2003025570A1 (en) | 2003-03-27 |
Family
ID=26622424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/009558 WO2003025570A1 (en) | 1999-05-18 | 2002-09-18 | Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050130123A1 (ja) |
EP (1) | EP1437593A1 (ja) |
JP (1) | JPWO2003025570A1 (ja) |
KR (1) | KR20040039366A (ja) |
CN (1) | CN1633599A (ja) |
CA (1) | CA2460778A1 (ja) |
WO (1) | WO2003025570A1 (ja) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005645A1 (en) * | 2003-06-13 | 2005-01-20 | Apath, Llc | Negative strand rna virus replicon |
JP2006180780A (ja) * | 2004-12-27 | 2006-07-13 | National Institute Of Advanced Industrial & Technology | 持続感染型センダイウイルスベクター |
WO2006134917A1 (ja) | 2005-06-14 | 2006-12-21 | Dnavec Corporation | 抗体の作製方法 |
WO2006137517A1 (ja) * | 2005-06-24 | 2006-12-28 | Dnavec Corporation | 幼少個体への遺伝子導入用ベクター |
WO2007083644A1 (ja) * | 2006-01-17 | 2007-07-26 | Dnavec Corporation | 新規タンパク質発現系 |
WO2007139178A1 (ja) | 2006-05-31 | 2007-12-06 | Dnavec Corporation | アルツハイマー病治療薬 |
WO2008007581A1 (fr) | 2006-07-13 | 2008-01-17 | Dnavec Corporation | Vecteur de virus paramyxoviridae non répliquant |
US7402427B2 (en) | 2002-04-30 | 2008-07-22 | Dnavec Research Inc. | Vectors with modified protease-dependent tropism |
JP2008529508A (ja) * | 2005-02-11 | 2008-08-07 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | ワクチンとしての複製欠損rna−ウイルス |
WO2008096811A1 (ja) | 2007-02-07 | 2008-08-14 | Dnavec Corporation | 弱毒化マイナス鎖rnaウイルス |
JP2008536476A (ja) * | 2005-04-20 | 2008-09-11 | ディナベック株式会社 | アルツハイマー病の治療のための安全性に優れた鼻腔内投与可能遺伝子ワクチン |
WO2008136438A1 (ja) | 2007-04-27 | 2008-11-13 | Kyushu University, National University Corporation | 遺伝子治療用ウイルスベクター |
US7521043B2 (en) | 2004-01-13 | 2009-04-21 | Dnavec Research Inc. | Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
WO2010008054A1 (ja) | 2008-07-16 | 2010-01-21 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
WO2010050586A1 (ja) | 2008-10-31 | 2010-05-06 | ディナベック株式会社 | 組み換え蛋白質の発現を増強する方法 |
WO2011083881A1 (ja) | 2010-01-08 | 2011-07-14 | 国立大学法人京都大学 | タウオパチー治療用ワクチン |
WO2012029770A1 (ja) | 2010-08-30 | 2012-03-08 | ディナベック株式会社 | 多能性幹細胞を誘導するための組成物およびその使用 |
EP2434020A2 (en) | 2004-01-22 | 2012-03-28 | Dnavec Research Inc. | Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter |
US8889118B2 (en) | 2004-06-24 | 2014-11-18 | Dna Vec Research Inc. | Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
WO2015046229A1 (ja) | 2013-09-24 | 2015-04-02 | ディナベック株式会社 | 多能性幹細胞の誘導効率を改善する方法 |
WO2019017438A1 (ja) | 2017-07-21 | 2019-01-24 | 株式会社Idファーマ | 標的配列を改変するためのポリヌクレオチドおよびその使用 |
WO2022050419A1 (ja) | 2020-09-04 | 2022-03-10 | Heartseed株式会社 | iPS細胞の品質改善剤、iPS細胞の製造方法、iPS細胞、及びiPS細胞製造用組成物 |
WO2022138964A1 (ja) | 2020-12-25 | 2022-06-30 | 国立大学法人京都大学 | 体細胞からのナイーブ型ヒトiPS細胞製造方法 |
WO2023277069A1 (ja) | 2021-06-30 | 2023-01-05 | 株式会社レプリテック | マイナス鎖rnaウイルスベクターの製造方法および製造されたマイナス鎖rnaウイルスベクター |
WO2023127871A1 (ja) * | 2021-12-27 | 2023-07-06 | 株式会社レプリテック | 温度感受性のマイナス鎖rnaウイルスまたはウイルスベクターおよびそのrnaゲノム |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005001082A1 (ja) * | 2003-06-30 | 2006-08-10 | 株式会社ディナベック研究所 | 高変異領域が改変された遺伝子を搭載するマイナス鎖rnaウイルスベクター |
WO2005042737A1 (ja) * | 2003-11-04 | 2005-05-12 | Dnavec Research Inc. | 遺伝子導入された樹状細胞の製造方法 |
CA2554198A1 (en) * | 2004-01-22 | 2005-08-04 | Dnavec Research Inc. | Process for producing virus vector |
WO2005097988A1 (ja) * | 2004-03-23 | 2005-10-20 | Dnavec Research Inc. | 組織の維持および/または修復に関連する骨髄関連細胞 |
JP4936482B2 (ja) * | 2007-04-13 | 2012-05-23 | 独立行政法人産業技術総合研究所 | 改良された持続感染型センダイウイルスベクター |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000070070A1 (fr) * | 1999-05-18 | 2000-11-23 | Dnavec Research Inc. | Vecteur de virus paramyxoviridae defectueux dans un gene enveloppe |
-
2002
- 2002-09-18 US US10/489,384 patent/US20050130123A1/en not_active Abandoned
- 2002-09-18 CN CNA028228766A patent/CN1633599A/zh active Pending
- 2002-09-18 KR KR10-2004-7003888A patent/KR20040039366A/ko not_active Application Discontinuation
- 2002-09-18 EP EP20020765579 patent/EP1437593A1/en not_active Withdrawn
- 2002-09-18 JP JP2003529148A patent/JPWO2003025570A1/ja active Pending
- 2002-09-18 WO PCT/JP2002/009558 patent/WO2003025570A1/ja not_active Application Discontinuation
- 2002-09-18 CA CA002460778A patent/CA2460778A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000070070A1 (fr) * | 1999-05-18 | 2000-11-23 | Dnavec Research Inc. | Vecteur de virus paramyxoviridae defectueux dans un gene enveloppe |
Non-Patent Citations (10)
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7709621B2 (en) | 2002-04-30 | 2010-05-04 | Dnavec Research Inc. | Vectors with modified protease-dependent tropism |
US7402427B2 (en) | 2002-04-30 | 2008-07-22 | Dnavec Research Inc. | Vectors with modified protease-dependent tropism |
WO2005005645A1 (en) * | 2003-06-13 | 2005-01-20 | Apath, Llc | Negative strand rna virus replicon |
US7585667B2 (en) | 2003-06-13 | 2009-09-08 | The United States Of America As Represented By The Department Of Health And Human Services | Negative strand RNA virus replicon |
US7521043B2 (en) | 2004-01-13 | 2009-04-21 | Dnavec Research Inc. | Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
US8741650B2 (en) | 2004-01-22 | 2014-06-03 | Dnavec Research Inc. | Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter |
EP2434020A2 (en) | 2004-01-22 | 2012-03-28 | Dnavec Research Inc. | Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter |
US8889118B2 (en) | 2004-06-24 | 2014-11-18 | Dna Vec Research Inc. | Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
JP2006180780A (ja) * | 2004-12-27 | 2006-07-13 | National Institute Of Advanced Industrial & Technology | 持続感染型センダイウイルスベクター |
JP2008529508A (ja) * | 2005-02-11 | 2008-08-07 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | ワクチンとしての複製欠損rna−ウイルス |
US11028409B2 (en) | 2005-02-11 | 2021-06-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Replication-deficient RNA viruses as vaccines |
JP2008536476A (ja) * | 2005-04-20 | 2008-09-11 | ディナベック株式会社 | アルツハイマー病の治療のための安全性に優れた鼻腔内投与可能遺伝子ワクチン |
WO2006134917A1 (ja) | 2005-06-14 | 2006-12-21 | Dnavec Corporation | 抗体の作製方法 |
WO2006137517A1 (ja) * | 2005-06-24 | 2006-12-28 | Dnavec Corporation | 幼少個体への遺伝子導入用ベクター |
WO2007083644A1 (ja) * | 2006-01-17 | 2007-07-26 | Dnavec Corporation | 新規タンパク質発現系 |
WO2007139178A1 (ja) | 2006-05-31 | 2007-12-06 | Dnavec Corporation | アルツハイマー病治療薬 |
WO2008007581A1 (fr) | 2006-07-13 | 2008-01-17 | Dnavec Corporation | Vecteur de virus paramyxoviridae non répliquant |
WO2008096811A1 (ja) | 2007-02-07 | 2008-08-14 | Dnavec Corporation | 弱毒化マイナス鎖rnaウイルス |
WO2008136438A1 (ja) | 2007-04-27 | 2008-11-13 | Kyushu University, National University Corporation | 遺伝子治療用ウイルスベクター |
JPWO2010008054A1 (ja) * | 2008-07-16 | 2012-01-05 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
EP3075850A1 (en) | 2008-07-16 | 2016-10-05 | IP Pharma Co., Ltd. | Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
US11136594B2 (en) | 2008-07-16 | 2021-10-05 | Id Pharma Co., Ltd. | Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
WO2010008054A1 (ja) | 2008-07-16 | 2010-01-21 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
US9695445B2 (en) | 2008-07-16 | 2017-07-04 | Id Pharma Co., Ltd. | Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
JP5763340B2 (ja) * | 2008-07-16 | 2015-08-12 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
US9127256B2 (en) | 2008-07-16 | 2015-09-08 | Dnavec Corporation | Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
JP2015164434A (ja) * | 2008-07-16 | 2015-09-17 | 株式会社Idファーマ | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
JP2016105729A (ja) * | 2008-07-16 | 2016-06-16 | 株式会社Idファーマ | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
WO2010050586A1 (ja) | 2008-10-31 | 2010-05-06 | ディナベック株式会社 | 組み換え蛋白質の発現を増強する方法 |
WO2011083881A1 (ja) | 2010-01-08 | 2011-07-14 | 国立大学法人京都大学 | タウオパチー治療用ワクチン |
WO2012029770A1 (ja) | 2010-08-30 | 2012-03-08 | ディナベック株式会社 | 多能性幹細胞を誘導するための組成物およびその使用 |
WO2015046229A1 (ja) | 2013-09-24 | 2015-04-02 | ディナベック株式会社 | 多能性幹細胞の誘導効率を改善する方法 |
US10975358B2 (en) | 2013-09-24 | 2021-04-13 | Id Pharma Co., Ltd. | Method for improving efficiency of inducing pluripotent stem cell |
WO2019017438A1 (ja) | 2017-07-21 | 2019-01-24 | 株式会社Idファーマ | 標的配列を改変するためのポリヌクレオチドおよびその使用 |
WO2022050419A1 (ja) | 2020-09-04 | 2022-03-10 | Heartseed株式会社 | iPS細胞の品質改善剤、iPS細胞の製造方法、iPS細胞、及びiPS細胞製造用組成物 |
WO2022138964A1 (ja) | 2020-12-25 | 2022-06-30 | 国立大学法人京都大学 | 体細胞からのナイーブ型ヒトiPS細胞製造方法 |
WO2023277069A1 (ja) | 2021-06-30 | 2023-01-05 | 株式会社レプリテック | マイナス鎖rnaウイルスベクターの製造方法および製造されたマイナス鎖rnaウイルスベクター |
WO2023127871A1 (ja) * | 2021-12-27 | 2023-07-06 | 株式会社レプリテック | 温度感受性のマイナス鎖rnaウイルスまたはウイルスベクターおよびそのrnaゲノム |
Also Published As
Publication number | Publication date |
---|---|
JPWO2003025570A1 (ja) | 2004-12-24 |
EP1437593A1 (en) | 2004-07-14 |
KR20040039366A (ko) | 2004-05-10 |
US20050130123A1 (en) | 2005-06-16 |
CN1633599A (zh) | 2005-06-29 |
CA2460778A1 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003025570A1 (en) | Method of examining (-) strand rna virus vector having lowered ability to form grains and method of constructing the same | |
AU3764901A (en) | Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | |
WO2003078455A3 (en) | Virus like particle from papillomavirus and their use in vaccine | |
WO1999036511A3 (en) | Feline immunodeficiency virus gene therapy vectors | |
WO2002059300A3 (en) | Double-stranded rna-mediated gene suppression | |
AU8016200A (en) | Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms | |
AU2001236042A1 (en) | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell | |
WO2003018767A3 (en) | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies | |
WO2003045427A3 (en) | Pharmaceutical composition for inducing an immune response in a human or animal | |
EP1712243A4 (en) | GENE THERAPY FOR TUMOR USING A NEGATIVE CHAIN RNA VIRAL VECTOR ENCODING AN IMMUNOSTIMULATORY CYTOKINE | |
MXPA03007535A (es) | Metodo para extraer virus de cultivo celular. | |
PT1329438E (pt) | Método de produção de produtos metálicos e cerâmicos | |
WO2005017130A3 (en) | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof | |
AU4971500A (en) | Production of novel newcastle disease virus strains from cdnas and improved liveattenuated newcastle disease vaccines | |
WO2003077863A3 (en) | Method for overexpression of zwitterionic polysaccharides | |
WO2002031137A3 (en) | Cytomegalovirus intron a fragments | |
AU2001269445A1 (en) | Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same | |
EP1946767A3 (en) | Autologous T-cell vaccines against multiple sclerosis | |
WO2005017100A3 (en) | Ribonucleases and methods of making them recombinantly | |
JP2007503812A5 (ja) | ||
WO2001004143A3 (en) | Prostase vaccine | |
WO2000004918A3 (de) | Mittel zur immuntherapie von tumorerkrankungen | |
AU2001263096A1 (en) | Compositions and methods for production of rna viruses and rna virus-based vector particles | |
WO2001025398A3 (en) | Process for inducing functional tolerance to gene transfer products | |
WO2006040485A3 (fr) | Macromolecule obtenue a partir d ' une culture de bifidobacterium et l' utilisation de celle-ci pour prevenir et traiter les rhumatismes inflammatoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003529148 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2460778 Country of ref document: CA Ref document number: 1020047003888 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002765579 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028228766 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002765579 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10489384 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002765579 Country of ref document: EP |